MedTrace Logo

Best Partograph Action Line to Prevent Prolonged Labour

NCT02911272 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 640

Last updated 2016-09-22

No results posted yet for this study

Summary

Objective: To compare active labour outcomes in nulliparous women at term supervised with a partograph with the action line placed at either 2 hours or 4 hours and to determine whether the 2-hour action line placement is better for the prevention of prolonged labour.

Design: Randomised controlled trial.

Setting: A university teaching hospital in Nigeria.

Population: Nulliparous women in labour at term.

Method: Nulliparous women in labour were randomly supervised with a partograph with the action line placed at 2 hours (n=320) or 4 hours (n=320). Oxytocin augmentation, when required, was used only at the 2-hour (n=87) or 4-hour (n=61) action lines. Progress monitoring was the same in both groups.

Main outcome measure: The primary outcome measure was the prolonged labour rate. The secondary outcome measures were the mode of delivery and neonatal outcome.

Conditions

  • Prolonged First Stage Labor - Prevention

Interventions

DEVICE

2-hour action line on WHO modified partograph

observations and findings in a woman in labour are recorded on this device (WHO modified partograph) in a graphic format in which the action line is located 2-hour from the alert line

DRUG

Oxytocin

Oxytocin augmentation of slow labour progress at the respective action line location on the WHO modified partograph

PROCEDURE

Forewater amniotomy

Forewater amniotomy at the vaginal examination confirming active phase labour

DEVICE

4-hour action line on WHO modified partograph

observations and findings in a woman in labour are recorded on this device (WHO modified partograph) in a graphic format in which the action line is located 4-hour from the alert line

Sponsors & Collaborators

  • University of Benin

    lead OTHER

Principal Investigators

  • Augustine AE Orhue, FRCOG · University of Benin

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911272 on ClinicalTrials.gov